EAM
TMDX icon

Eventide Asset Management’s Transmedics TMDX Stock Holding History

Eventide Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.5M Buy
548,874
+50
+0% +$4.23K 0.49% 70
2026
Q1 		$54.5M Buy
548,824
+557
+0.1% +$72.7K 0.9% 34
2025
Q4 		$66.7M Buy
548,267
+971
+0.2% +$122K 1.04% 23
2025
Q3 		$61.4M Sell
547,296
-59
-0% -$6.91K 1.01% 25
2025
Q2 		$73.3M Sell
547,355
-130,626
-19% -$14.3M 1.29% 18
2025
Q1 		$45.6M Buy
677,981
+279
+0% +$19.2K 0.91% 37
2024
Q4 		$42.2M Sell
677,702
-12,930
-2% -$1.2M 0.77% 44
2024
Q3 		$108M Sell
690,632
-454,798
-40% -$70.1M 1.87% 10
2024
Q2 		$173M Sell
1,145,430
-24,465
-2% -$2.93M 2.95% 2
2024
Q1 		$86.5M Buy
1,169,895
+175,655
+18% +$14.5M 1.36% 20
2023
Q4 		$78.5M Buy
994,240
+68,884
+7% +$4.16M 1.28% 28
2023
Q3 		$50.7M Buy
925,356
+857,895
+1,272% +$61.8M 0.91% 37
2023
Q2 		$5.67M Buy
+67,461
New +$5.16M 0.1% 127
2021
Q4 		– Sell
-77,364
Closed -$2.56M – 161
2021
Q3 		$2.56M Hold
77,364
– – 0.03% 148
2021
Q2 		$2.57M Buy
+77,364
New +$2.14M 0.03% 146

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Eventide Asset Management's TMDX Position: Q2 2026 in Review

Eventide Asset Management increased its Transmedics (TMDX) stake by 0.01% in Q2 2026, buying an estimated $4.23K and bringing the position to 548,874 shares worth $36.5M. The position accounts for 0.49% of the portfolio, ranked #70.

Eventide Asset Management first reported a position in TMDX in Q2 2021 and has held it in 15 quarters since. The position peaked at $173M in Q2 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Eventide Asset Management held 548,874 shares of Transmedics worth $36.5M as of Q2 2026.
  • Eventide Asset Management bought 50 Transmedics shares in Q2 2026, an estimated $4.23K.
  • Transmedics made up 0.49% of Eventide Asset Management's portfolio in Q2 2026, its #70 holding.
  • Eventide Asset Management first reported a position in Transmedics in Q2 2021 and has held it in 15 quarters since.
  • Eventide Asset Management's Transmedics position peaked at $173M in Q2 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.